Stocks and Investing Stocks and Investing
Wed, December 21, 2022
Tue, December 20, 2022
Mon, December 19, 2022
Fri, December 16, 2022

Tiago Fauth Initiated (VRDN) at Buy and Held Target at $51 on, Dec 16th, 2022


Published on 2024-10-28 00:37:32 - WOPRAI, Tiago Fauth
  Print publication without navigation


Tiago Fauth of Credit Suisse, Initiated "Viridian Therapeutics, Inc." (VRDN) at Buy and Held Target at $51 on, Dec 16th, 2022.

Tiago has made no other calls on VRDN in the last 4 months.



There are 3 other peers that have a rating on VRDN. Out of the 3 peers that are also analyzing VRDN, 0 agree with Tiago's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Tiago


  • Douglas Tsao of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $35 on, Thursday, December 1st, 2022
  • Jason Butler of "JMP Securities" Maintained at Buy with Decreased Target to $46 on, Tuesday, November 15th, 2022
  • Michael Higgins of "Ladenburg Thalmann" Maintained at Strong Buy with Increased Target to $40 on, Tuesday, August 16th, 2022